10/15/2021

Award for Cambridge Neuroscientist

Michel Goedert is honored for his groundbreaking research on the molecular mechanisms of neurodegenerative diseases.

10/13/2021

In Neurodegenerative Diseases, Brain Immune Cells Have a “Ravenous Appetite” for Sugar

The Interpretation of Certain Brain Scans Needs Rethinking – Study in „Science Translational Medicine“

10/11/2021

Researchers Find Warning Signs for Dementia in the Blood

Levels of Certain microRNAs Indicate Risk for Cognitive Decline.

07/06/2021

„Tuning“ for Brain Scanners

DZNE coordinates international research project on Ultra-High Field MRI.

06/29/2021

How Environmental Factors Could Provide for a Young Brain

Study in “Nature Communications” on epigenetic mechanisms in the hippocampus.

06/23/2021

Smart Biomarkers to Empower Drug Development for Brain Diseases

Dresden Researchers Awarded Prestigious Funding by the Helmholtz Association to Validate a Novel Approach that Combines Neuroelectronics and Artificial Intelligence.

06/08/2021

Alzheimer’s: U.S. Regulatory Authority Approves Use of “Aducanumab” on the Condition of Further Studies

Statement by Prof. Pierluigi Nicotera, Scientific Director and Chairman of the DZNE’s Executive Board.

05/26/2021

AI with Swarm Intelligence

Publication in „Nature“: Researchers led by DZNE analyze medical data with a novel artificial intelligence technology. Collaboration with Hewlett Packard Enterprise.

05/21/2021

Studies on “Long COVID”

DZNE researchers look into the long-term effects of an infection with the coronavirus.

05/10/2021

Better care for people with dementia at home: Ambulatory care specialists take over medical tasks for the first time

The DZNE is leading a study project in which specialists in geriatric and nursing care are being specifically further qualified.